Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

Interleukin-17 and type 17 helper T cells.

Miossec P, Korn T, Kuchroo VK.

N Engl J Med. 2009 Aug 27;361(9):888-98. doi: 10.1056/NEJMra0707449. Review. No abstract available.

PMID:
19710487
2.

Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.

Fujimoto M, Serada S, Mihara M, Uchiyama Y, Yoshida H, Koike N, Ohsugi Y, Nishikawa T, Ripley B, Kimura A, Kishimoto T, Naka T.

Arthritis Rheum. 2008 Dec;58(12):3710-9. doi: 10.1002/art.24126.

3.

T(H)-17 cells in the circle of immunity and autoimmunity.

Bettelli E, Oukka M, Kuchroo VK.

Nat Immunol. 2007 Apr;8(4):345-50. Review.

PMID:
17375096
4.

[Rheumatoid arthritis].

Tsukamoto M, Takeuchi T.

Nihon Rinsho. 2012 Nov;70 Suppl 8:534-8. Japanese. No abstract available.

PMID:
23513897
5.

Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.

Sutton CE, Lalor SJ, Sweeney CM, Brereton CF, Lavelle EC, Mills KH.

Immunity. 2009 Aug 21;31(2):331-41. doi: 10.1016/j.immuni.2009.08.001. Epub 2009 Aug 13.

6.

The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4.

Brüstle A, Heink S, Huber M, Rosenplänter C, Stadelmann C, Yu P, Arpaia E, Mak TW, Kamradt T, Lohoff M.

Nat Immunol. 2007 Sep;8(9):958-66. Epub 2007 Aug 5.

PMID:
17676043
7.

Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis.

Frey O, Meisel J, Hutloff A, Bonhagen K, Bruns L, Kroczek RA, Morawietz L, Kamradt T.

Ann Rheum Dis. 2010 Aug;69(8):1495-501. doi: 10.1136/ard.2009.119164. Epub 2010 May 24.

PMID:
20498202
8.

Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.

Hohki S, Ohguro N, Haruta H, Nakai K, Terabe F, Serada S, Fujimoto M, Nomura S, Kawahata H, Kishimoto T, Naka T.

Exp Eye Res. 2010 Aug;91(2):162-70. doi: 10.1016/j.exer.2010.04.009. Epub 2010 Apr 24.

PMID:
20420831
9.

The IL-12/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis.

Cornelissen F, van Hamburg JP, Lubberts E.

Curr Opin Investig Drugs. 2009 May;10(5):452-62. Review.

PMID:
19431078
10.

Mouse Th17 cells: current understanding of their generation and regulation.

Dong C.

Eur J Immunol. 2009 Mar;39(3):640-4. doi: 10.1002/eji.200839076.

11.

An insight into molecular mechanisms of human T helper cell differentiation.

Rautajoki KJ, Kylaniemi MK, Raghav SK, Rao K, Lahesmaa R.

Ann Med. 2008;40(5):322-35. doi: 10.1080/07853890802068582. Review.

PMID:
18484344
12.

Interleukin 6 receptor as a target for the treatment of rheumatoid arthritis.

Choy E.

Ann Rheum Dis. 2003 Nov;62 Suppl 2:ii68-9. No abstract available.

13.

The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR.

Cell. 2006 Sep 22;126(6):1121-33.

14.

Interleukin-17 in fashion, at last: ten years after its description, its cellular source has been identified.

Miossec P.

Arthritis Rheum. 2007 Jul;56(7):2111-5. Review. No abstract available.

15.

Immunology: narcissistic helpers.

Palmer MT, Weaver CT.

Nature. 2007 Jul 26;448(7152):416-8. No abstract available.

PMID:
17653176
16.

Autoimmune inflammation from the Th17 perspective.

Furuzawa-Carballeda J, Vargas-Rojas MI, Cabral AR.

Autoimmun Rev. 2007 Jan;6(3):169-75. Epub 2006 Nov 14.

PMID:
17289553
17.

Regulation of T helper 17 differentiation by orphan nuclear receptors: it's not just ROR gamma t anymore.

Sundrud MS, Rao A.

Immunity. 2008 Jan;28(1):5-7. doi: 10.1016/j.immuni.2007.12.006.

18.

IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?

Lubberts E.

Cytokine. 2008 Feb;41(2):84-91. Epub 2007 Nov 26. Review.

PMID:
18039580
19.

Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A.

Okiyama N, Sugihara T, Iwakura Y, Yokozeki H, Miyasaka N, Kohsaka H.

Arthritis Rheum. 2009 Aug;60(8):2505-12. doi: 10.1002/art.24689.

20.

Interplay between effector Th17 and regulatory T cells.

Awasthi A, Murugaiyan G, Kuchroo VK.

J Clin Immunol. 2008 Nov;28(6):660-70. doi: 10.1007/s10875-008-9239-7. Epub 2008 Sep 23.

PMID:
18810613

Supplemental Content

Support Center